10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
Pre-Market: 20:00
10X Genomics EPS Diluted (Quarterly) : -0.138 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.138 |
| March 31, 2026 | -0.105 |
| December 31, 2025 | -0.1279 |
| September 30, 2025 | -0.2189 |
| June 30, 2025 | 0.2774 |
| March 31, 2025 | -0.2802 |
| December 31, 2024 | -0.4032 |
| September 30, 2024 | -0.2961 |
| June 30, 2024 | -0.3156 |
| March 31, 2024 | -0.5021 |
| December 31, 2023 | -0.4129 |
| September 30, 2023 | -0.7898 |
| June 30, 2023 | -0.5348 |
| March 31, 2023 | -0.4389 |
| December 31, 2022 | -0.15 |
| September 30, 2022 | -0.3673 |
| June 30, 2022 | -0.5675 |
| March 31, 2022 | -0.3754 |
| December 31, 2021 | -0.1649 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.1549 |
| June 30, 2021 | -0.1006 |
| March 31, 2021 | -0.1062 |
| December 31, 2020 | -3.870 |
| September 30, 2020 | -0.6498 |
| June 30, 2020 | -0.4058 |
| March 31, 2020 | -0.2184 |
| December 31, 2019 | -0.0741 |
| September 30, 2019 | -0.0998 |
| June 30, 2019 | -0.113 |
| March 31, 2019 | -0.0378 |
| December 31, 2018 | -0.7921 |
| September 30, 2018 | -0.1609 |
| June 30, 2018 | -0.0621 |
| March 31, 2018 | -0.1646 |
| December 31, 2017 | -0.0439 |
| September 30, 2017 | -0.0476 |
| June 30, 2017 | -0.0394 |
| March 31, 2017 | -0.0659 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Twist Bioscience Corp. | -0.5617 |
| Tempus AI, Inc. | 0.0309 |
| Personalis, Inc. | -0.3005 |
| Alamar Biosciences, Inc. (California) | -0.1902 |
| Beam Therapeutics, Inc. | -1.176 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.93M |
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| Enterprise Value | 11.71B |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.63% |
| Normalized Earnings Yield | -0.6433 |